Somatostatin Analogues

From Research to Clinical Practice

Alicja Hubalewska-Dydejczyk, Alberto Signore, Marion de Jong, Rudi A. Dierckx, John Buscombe, Christophe Van de Wiele, Alicja Hubalewska-Dydejczyk, Alberto Signore, Marion de Jong, Rudi A. Dierckx, John Buscombe, Christophe Van de Wiele

• Publisher: Wiley
• Year: 2015
• ISBN:
  9781119031383
• Edition: 1
• Topic: Biological Sciences
• Subtopic: Biochemistry
• Index: Biological Sciences

Featuring chapters from specialists in endocrinology, physiology, pathology, and nuclear medicine, this book provides a multidisciplinary approach to a wide variety of issues concerning somatostatin and its analogues. The book:

• Provides the most up-to-date coverage of somatostatin analog use in diagnostic and therapy
• Integrating the specialties of endocrinology, physiology, pathology, and nuclear medicine, providing the multidisciplinary approach to the topic
• Focuses on future applications, novel compounds, and areas for further research
• Covers topics by authors who are renowned experts and researchers in the field

Table of contents

• COVER
• TITLE PAGE
• TABLE OF CONTENTS
• CONTRIBUTORS
• PREFACE
• ACKNOWLEDGMENTS
• 1 SOMATOSTATIN: THE HISTORY OF DISCOVERY
• 2 PHYSIOLOGY OF ENDOGENOUS SOMATOSTATIN FAMILY: SOMATOSTATIN RECEPTOR SUBTYPES, SECRETION, FUNCTION AND REGULATION, AND ORGAN SPECIFIC DISTRIBUTION
• 3 SOMATOSTATIN RECEPTORS IN MALIGNANCIES AND OTHER PATHOLOGIES
• 4 THE USE OF RADIOLABELED SOMATOSTATIN ANALOGUE IN MEDICAL DIAGNOSIS: INTRODUCTION
• 4.1 SOMATOSTATIN RECEPTOR SCINTIGRAPHY-SPECT
• 4.2 MOLECULAR IMAGING OF SOMATOSTATIN RECEPTOR-POSITIVE TUMORS USING PET/CT
• 4.3 OTHER RADIOPHARMACEUTICALS FOR IMAGING GEP-NET
• 4.4 THE PLACE OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN CLINICAL SETTING: INTRODUCTION
• 4.4.1 SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN MANAGEMENT OF PATIENTS WITH NEUROENDOCRINE NEOPLASMS
• 4.4.2 THE PLACE OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY AND OTHER FUNCTIONAL IMAGING MODALITIES IN THE SETTING OF PHEOCHROMOCYTOMA AND PARAGANGLIOMA
• 4.4.3 SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN MEDULLARY THYROID CANCER
• 4.4.4 SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN OTHER TUMORS IMAGING
• 4.4.5 SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN INFLAMMATION AND INFECTION IMAGING
• 5 SOMATOSTATIN ANALOGUES IN PHARMACOTHERAPY: INTRODUCTION
• 5.1 SOMATOSTATIN ANALOGUES IN PHARMACOTHERAPY
• 5.2 PITUITARY TUMOR TREATMENT WITH SOMATOSTATIN ANALOGUES
• 5.3 SOMATOSTATIN ANALOGUES IN PHARMACOTHERAPY OF GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS
• 5.4 SOMATOSTATIN ANALOGUES USE IN OTHER THAN ENDOCRINE TUMOR INDICATIONS
• 6 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY USING RADIOLABELED SOMATOSTATIN ANALOGUES: AN INTRODUCTION
• 6.1 SOMATOSTATIN ANALOGUES AND RADIONUCLIDES USED IN THERAPY
• 6.2 PRRT DOSIMETRY
• 6.3 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT): CLINICAL APPLICATION
• 6.4 DUO-PRRT OF NEUROENDOCRINE TUMORS USING CONCURRENT AND SEQUENTIAL ADMINISTRATION OF Y-90- AND LU-177-LABELED SOMATOSTATIN ANALOGUES
• 6.5 NONSYSTEMIC TREATMENT OF LIVER METASTASES FROM NEUROENDOCRINE TUMOR
• 6.6 PEPTIDE RECEPTOR RADIONUCLIDE THERAPY: OTHER INDICATIONS
• 7 SOMATOSTATIN ANALOGS
• 8 RADIOLABELED SOMATOSTATIN RECEPTOR ANTAGONISTS
• 9 CORTISTATINS AND DOPASTATINS
• INDEX
• END USER LICENSE AGREEMENT